scispace - formally typeset
J

Joel Morganroth

Researcher at National Institutes of Health

Publications -  26
Citations -  2038

Joel Morganroth is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Nadolol & Cholestyramine. The author has an hindex of 16, co-authored 26 publications receiving 1964 citations.

Papers
More filters
Journal ArticleDOI

Comparative Left Ventricular Dimensions in Trained Athletes

TL;DR: Recognizing greater left ventricular mass and volume in well-trained athletes aids in interpreting values deviating from "normal" limits.
Journal ArticleDOI

The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.

TL;DR: The clinical and biochemical features of type III hyperlipoproteinemia are described in 49 patients from 23 to 70 years of age, and an increase in very low-density lipoproteins (VLDL) of abnormal chemical composition was the basis for diagnosis.
Journal ArticleDOI

Type III hyperlipoproteinemia: an analysis of two contemporary definitions.

TL;DR: It is concluded that the chemical index to VLD lipoprotein composition is the better, albeit, temporary definition for this disorder.
Journal ArticleDOI

Alteration of the Cytotoxic Action of Sensitized Lymphocytes by Cholinergic Agents and Activators of Adenylate Cyclase

TL;DR: The cytotoxic action of lymphocytes upon cells bearing alloantigens to which they are sensitized is inhibited by agents that elevate intracellular amounts of 3':5'-cyclic AMP, and cholinergic agents, added in the range of 1 to 100 pM, enhance cytotoxicity, an effect that is blocked by atropine.
Journal ArticleDOI

Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery.

TL;DR: The degree of mediastinal blood loss did not correlate with age, sex, mean total operative time, bypass time, or number of vessels diseased or bypassed, and the potential effect of platelet active and antithrombotic agents prescribed preoperatively on bleeding complications after coronary-artery bypass graft surgery was evaluated.